SMS Pharmaceuticals Limited (BOM:532815)

Market Cap	31.57B +89.8%
Revenue (ttm)	8.97B +15.0%
Net Income	895.91M +35.5%
EPS	9.61 +22.9%
Shares Out	n/a
PE Ratio	35.24
Forward PE	n/a
Dividend	0.40 (0.13%)
Ex-Dividend Date	Sep 22, 2025

Volume	9,652
Average Volume	10,443
Open	346.00
Previous Close	353.20
Day's Range	334.00 - 347.70
52-Week Range	175.00 - 359.95
Beta	n/a
RSI	58.34
Earnings Date	Feb 7, 2026

About SMS Pharmaceuticals

SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. It offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides. The company exports its products to approximately 75 countries. SMS Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Hyderabad, In...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1987
• Employees: 1,470
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532815

Financial Performance

In fiscal year 2025, SMS Pharmaceuticals's revenue was 7.83 billion, an increase of 10.36% compared to the previous year's 7.09 billion. Earnings were 691.36 million, an increase of 38.75%.